POVA-TIE: Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19.

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Recruiting
CT.gov ID
NCT04386720
Collaborator
(none)
20
1
24
0.8

Study Details

Study Description

Brief Summary

Mechanical ventilation in ARDS requires protective ventilation and PEEP. Airway closer has to be overcome to reduce lung heterogeneity, AOP is measured globally with a ventilator PV curve without PEEP. EIT derived PV curve is another method that could determine heterogeneity of AOP between both lung.

This study aims to determine whether AOP measured with EIT derived PV curve is similar to AOP on the ventilator PV curve and see if AOP is different between lungs.

If airway closer is higher on one lung, global AOP on the ventilator PV curve probably estimates the other lung.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Scientific justification:

    In one third of Acute Respiratory Distress Syndrome (ARDS), tidal inflation starts when an airway opening pressure (AOP) is overcome 1. This phenomenon of airway closure has been underestimated and misinterpreted. Recent research demonstrates that airway closure is a matter of concern as it participates to the heterogeneity of tidal ventilation distribution and it can amplify Ventilator Induced Lung Injury (VILI). The detection of airway closure and the measurement of AOP need a pressure volume curve at low flow and no positive end expiratory pressure (PEEP). However, this will measure a global AOP whereas ventilation is heterogeneous between the two lungs in ARDS. EIT is an interesting monitoring tool that could allow EIT derived PV curve construction with measurement of regional AOP2, right vs left lung. The investigor wants to compare global AOP on ventilator PV curve with left and right lung EIT derived AOP measurements. Recent Covid 19 pneumoniae is responsible for numerous acute respiratory distress with severe hypoxemia. Phenotypes are discussed with differences in terms of respiratory mechanics. It is therefore important to describe specifically Covid 19 patients with ARDS.

    Strategy description:

    Patients with moderate to severe ARDS equipped with EIT will be included. PEEP will be titrated with PEEP-EIT method. A classical low flow PV curve from without PEEP will be done, the acquisition of EIT data during PV curve will be analysed secondary with a dedicated software. PV curve on the ventilator will be analysed to determine if there is an airway closer phenomenon. Reconstruction of EIT derived PV curve will determine, first: if there is a left and/or right lung airway closer phenomenon, and second: the value of each lung AOP.

    Follow up description:
    • Measurement of ventilator pressures, flow and volume before/during/after the PV curve.

    • Last chest X Ray and arterial blood gases,

    • Haemodynamic data.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    20 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom With Pressure Volume Curve on the Ventilator and With Electrical Impedance Tomography (EIT) Derived Method in Comparison of the Curves in Patients With or Without Covid 19 Pneumoniae.
    Actual Study Start Date :
    May 25, 2020
    Anticipated Primary Completion Date :
    May 25, 2022
    Anticipated Study Completion Date :
    May 25, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Comparison of the PV curves [At inclusion day]

      global ventilator method vs regional EIT derived method in all patients

    Secondary Outcome Measures

    1. Comparison of regional AOP [At inclusion day]

      Global ventilator method vs regional EIT derived method in regional AOP, right and left lungs

    2. Comparison of the different AOPs with the level of PEEP [At inclusion day]

      Comparison selected by the EIT-PEEP method

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    • Inclusion criteria:

    • Patients hospitalized in the ICU and who suffered moderate to severe ARDS (Berlin criteria) equipped EIT over the age of 18.

    • Exclusion criteria:

    • Broncho-pleural leaks

    • ECMO

    • Pregnant or breastfeeding woman.

    • Guardianship or curatorship

    • Deprived of liberty

    • No health insurance

    • Impossibility to correctly position the EIT belt (e.g., dressings, chest drainage, etc.)

    • Contra indications to EIT (e.g., implantable cardiac defibrillator, pacemaker, instable spinal lesions)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 HOPITAL HAUT-LEVEQUE - Service RĂ©animation thoracique Pessac France 33604

    Sponsors and Collaborators

    • University Hospital, Bordeaux

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Bordeaux
    ClinicalTrials.gov Identifier:
    NCT04386720
    Other Study ID Numbers:
    • CHUBX 2020/15
    First Posted:
    May 13, 2020
    Last Update Posted:
    Jun 7, 2021
    Last Verified:
    Jun 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Bordeaux
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 7, 2021